Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Whole-Body Irradiation × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 40 Myelodysplastic Syndromes 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Hematologic Neoplasms 21 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19 Leukemia, Biphenotypic, Acute 17 Leukemia, Lymphocytic, Chronic, B-Cell 16 Myeloproliferative Disorders 15 Hodgkin Disease 15 Leukemia, Myelomonocytic, Chronic 14 Leukemia 13 Multiple Myeloma 12 Lymphoma, Non-Hodgkin 12 Anemia, Refractory, with Excess of Blasts 12 Primary Myelofibrosis 9 Lymphoma 9 Burkitt Lymphoma 9 Lymphoma, Follicular 8 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Anemia, Aplastic 7 Neoplasms, Plasma Cell 6 Lymphoma, T-Cell 6 Leukemia, Prolymphocytic 6 Leukemia, Myeloid 6 Graft vs Host Disease 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Polycythemia Vera 4 Neoplasms 4 Leukemia, Myeloid, Accelerated Phase 4

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡